Searched for
TERIFLUNOMIDE
Fresh tailwinds emerge as government comes in again with intent: 7 pharma stocks with upside potential of up to 36%Budget 2026 underlines the government’s intent – in terms of the sectors it will focus on. Now, it is not all of a sudden that the governme...- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of more than 26% in 1 yearThe way things have panned out in the last few weeks clearly indicates that there is a higher probability of the market staying bullish. Th...
- AI can have medical care biases too, a study revealsDespite identical clinical details, the AI models occasionally altered decisions based on patients' personal characteristics, affecting pri...
- Stocks in news: BPCL, Adani Wilmar, Vodafone Idea, Cyient, Concord BiotechIn today's trade, shares of BPCL, Adani Wilmar, Vodafone Idea, Cyient, Concord Biotech among others will be in focus due to various news de...
- Ignore noise on the street, stick to basics: 5 stocks from different sectors with an upside potential of up to 38%The markets are volatile with a bearish bias, and the Nifty and Sensex are bearing the brunt. A closer look, however, reveals that, even in...
- Getting back into shape? 6 Indian pharma stocks with upside potential of up to 41%The year 2024, started with a correction in nifty, but one set of stocks which were able to outperform were pharma stocks. While it might a...
- These largecaps have ‘strong buy’ & ‘buy’ recos and upside potential of more than 20%In the last few weeks, the range in which the nifty had been moving has become broader as the volatility has increased both due to internat...
- These largecaps have ‘strong buy’ & ‘buy’ recos and upside scope of over 20%As the market moves from clearly bullish mode to volatile mode with a bearish bias, there will be readjustment in valuation across markets....
- These largecaps have ‘strong buy’ & ‘buy’ recos with upside potential of over 20%In volatile markets, where there is a readjustment in valuation across midcap space, it is only a matter of time that the concept of relati...
- These largecaps have ‘strong buy’ & ‘buy’ recos and upside potential of more than 20%While the correction has been going on in the market since the middle of July, it is only on days like Monday where everyone on the street ...
- Nifty healthcare index stocks; Staying bullish on select pharma and hospitalsWhile they clubbed together, the operating matrix of a pharma company making drugs and hospital and a diagnostic company are very different...
- Nifty healthcare index stocks analysts suggest buying have potential upside of more than 19%Except for a pocket in which demand for covid drugs led to sharp surge in pharma stocks, the pharma sector had been under pressure for a lo...
- These largecaps have ‘Strong Buy’ & ‘Buy’ reco and upside potential of more than 25%As the NIFTY and broader market recovers, analysts are bullish on select large cap stock. Making to the list are a host of companies from d...
- These largecaps have ‘strong buy’ & ‘buy’ reco and upside potential of over 25%As the NIFTY and broader market recovers, analysts are bullish on select large cap stock. Making to the list are a host of companies from d...
- These largecaps have ‘strong buy’ & ‘buy’ recos and upside potential of over 25%As the NIFTY and broader market recovers, analysts are bullish on select large cap stock. Making to the list are a host of financial instit...
- Should you stick to largecaps amid volatile Nifty? These 4 stocks have up to 30% upside scopeAs volatility increases, the focus in the market is shifting to stocks which are considered as relatively defensive. These stocks tend to f...
- A consistent wealth creator among 11 stocks that have an upside potential of over 25%As the market witnesses volatile movement there are few large cap stocks which are still finding favor with analysts. After the recent corr...
- Alembic Pharma gets USFDA nod for 2 generic productsThe product is generic version of Sanofi-Aventis US LLC's Aubagio tablets in the same strengths.
- In Focus: Sun Pharma, Jet Airways, Prabhat Dairy, Laurus Labs and Maruti SuzukiHere are a few stocks which may buzz the most in today’s session.
- Glenmark gets USFDA nod for multiple sclerosis medicationThe approved product is generic version of Sanofi-Aventis US' Aubagio.
Load More
